QCM Cayman’s ResMed RMD Stock Holding History

QCM Cayman’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,024	Closed	-$233K	–	346
2016 Q1	$233K	Buy	+4,024	New	+$228K	0.16%	118

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

QCM Cayman's RMD Position: Q2 2016 in Review

QCM Cayman sold out of ResMed (RMD) in Q2 2016, closing a stake of 4,024 shares — an estimated $233K sold.

QCM Cayman first reported a position in RMD in Q1 2016 and held it in 1 quarter. The position peaked at $233K in Q1 2016. 361 funds tracked by Wall St. Rank hold RMD as of Q2 2016.

QCM Cayman reported no remaining ResMed position as of Q2 2016 after selling out during the quarter.
QCM Cayman sold 4,024 ResMed shares in Q2 2016, an estimated $233K.
QCM Cayman first reported a position in ResMed in Q1 2016 and held it in 1 quarter.
QCM Cayman's ResMed position peaked at $233K in Q1 2016.
361 funds tracked by Wall St. Rank held ResMed as of Q2 2016.

Based on QCM Cayman's 13F filing for Q2 2016, filed 15 Aug 2016.